
欧洲透皮医疗贴剂市场预测至 2028 年 - COVID-19 影响和区域分析 - 按类型(单层药物粘合剂、多层药物粘合剂、储库、蒸气贴剂和基质)、应用(神经系统疾病) 、疼痛管理、戒烟、心血管疾病、激素治疗等)和分销渠道(医院药房、零售药房和在线药房)
No. of Pages: 158 | Report Code: BMIRE00028755 | Category: Life Sciences
No. of Pages: 158 | Report Code: BMIRE00028755 | Category: Life Sciences
透皮贴剂医疗贴片用于为患有心脏病、中风、糖尿病、癌症、肥胖症和关节炎等慢性疾病的人提供药物。
心脏贴片提供了一个极好的平台用于改善细胞植入。例如,最近开发的血管化心脏补片显示出治疗缺血性心脏损伤的巨大潜力。硝酸甘油透皮贴剂用于预防冠状动脉疾病患者的心绞痛(胸痛)发作。它的作用是放松血管并减轻心脏的压力,从而降低对氧气的需求。然而,这些贴剂不能用于治疗已经开始的心绞痛发作。
卡巴拉汀贴剂用于治疗与轻度、中度或重度阿尔茨海默病相关的痴呆(记忆丧失)疾病或与帕金森病相关的轻度至中度痴呆。卡巴拉汀和多奈哌齐是胆碱酯酶抑制剂,表现出剂量-反应关系,药物剂量越高,疗效越好。作为一种亲脂性和亲水性的小分子,卡巴拉汀在化学上非常适合透皮给药。卡巴拉汀贴片所采用的技术使其外观小而薄。因此,卡巴拉汀贴剂可以快速、轻松地获得高剂量疗效。
因此,慢性病患病率的不断上升促进了对医疗贴剂的需求。< /p>
欧洲透皮医疗贴剂市场分为英国、德国、西班牙、意大利和欧洲其他国家。 2022年,英国在欧洲透皮医疗贴剂市场中占据最大份额。患有慢性病和病毒性疾病的患者数量不断增加,研发活动不断增加,是推动透皮医疗贴剂市场的关键因素。此外,慢性病的日益流行也有利于市场扩张。
欧洲透皮医疗贴剂市场按类型、应用、分销渠道细分和国家。
根据类型,市场分为单层药物粘合剂、多层药物粘合剂、储库、蒸气贴片和基质。基质细分市场在 2023 年占据最大的市场份额。
根据应用,欧洲透皮医疗贴剂市场分为神经系统疾病、疼痛管理、尼古丁戒断、心血管疾病、激素疗法等。 2023年,疼痛管理细分市场占据最大市场份额。
根据分销渠道,欧洲透皮医疗贴剂市场分为医院药房、零售药房和在线药房。 2023 年,医院药房细分市场占据最大市场份额。
根据国家/地区,欧洲透皮医疗贴剂市场分为德国、法国、英国、意大利、西班牙和欧洲其他国家。德国在 2023 年占据了市场份额。
Boehringer Ingelheim International GmbH、Endo International Inc、Hisamitsu Pharmaceutical Co Inc、Johnsons and Johnsons、Medline Industries LP、Novartis AG、Teva Pharmaceutical Industries Ltd.、UCB SA 和 Viatris Inc 是该地区透皮医疗贴剂市场的领先公司。
Strategic insights for Europe Transdermal Medical Patch involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2023 | US$ 2,434.09 Million |
Market Size by 2028 | US$ 3,079.58 Million |
Global CAGR (2023 - 2028) | 4.8% |
Historical Data | 2021-2022 |
Forecast period | 2024-2028 |
Segments Covered |
By 类型
|
Regions and Countries Covered | 欧洲
|
Market leaders and key company profiles |
The regional scope of Europe Transdermal Medical Patch refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Europe Transdermal Medical Patch Market is valued at US$ 2,434.09 Million in 2023, it is projected to reach US$ 3,079.58 Million by 2028.
As per our report Europe Transdermal Medical Patch Market, the market size is valued at US$ 2,434.09 Million in 2023, projecting it to reach US$ 3,079.58 Million by 2028. This translates to a CAGR of approximately 4.8% during the forecast period.
The Europe Transdermal Medical Patch Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Transdermal Medical Patch Market report:
The Europe Transdermal Medical Patch Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Transdermal Medical Patch Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Transdermal Medical Patch Market value chain can benefit from the information contained in a comprehensive market report.